Estimated preference weights | Odds ratio | |||||
---|---|---|---|---|---|---|
Attributes | Level | Coefficient | Standard Error | P value | Odds ratio | 95% CI |
Treatment method | Only medication | −0.090 | 0.046 | 0.048 | reference | |
Stent intervention + medication maintenance | 0.013 | 0.046 | 0.780 | 1.109 | (1.014–1.212) | |
Bypass surgery + medication maintenance | 0.078 | 0.045 | 0.088 | 1.183 | (1.082–1.293) | |
Mortality within five years | 1% | 0.727 | 0.046 | < 0.001 | reference | |
20% | 0.007 | 0.044 | 0.875 | 0.487 | (0.447–0.530) | |
40% | −0.734 | 0.049 | < 0.001 | 0.232 | (0.211–0.255) | |
Complication rate within one year | 0% | 0.208 | 0.045 | < 0.001 | reference | |
8% | 0.002 | 0.045 | 0.969 | 0.814 | (0.745–0.890) | |
16% | −0.209 | 0.046 | < 0.001 | 0.659 | (0.602–0.721) | |
Treatment duration | 3 days | 0.078 | 0.045 | 0.084 | reference | |
10 days | 0.211 | 0.045 | < 0.001 | 1.142 | (1.044–1.248) | |
lifetime | −0.289 | 0.047 | < 0.001 | 0.693 | (0.633–0.759) | |
Expense | RMB$50000 | 0.106 | 0.069 | 0.124 | reference | |
RMB$100000 | 0.050 | 0.069 | 0.466 | 0.946 | (0.826–1.083) | |
RMB$150000 | 0.054 | 0.069 | 0.433 | 0.949 | (0.829–1.086) | |
RMB$200000 | −0.061 | 0.069 | 0.378 | 0.846 | (0.738–0.969) | |
RMB$250000 | −0.149 | 0.070 | 0.033 | 0.774 | (0.675–0.888) | |
Log-likelihood | − 1313 | |||||
Log likelihood of model without predictors | − 1950 | |||||
Akaike Info Criterion (AIC) | 2708 | |||||
Bayesian Information Criterion (BIC) | 2933 |